Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis.
Both the diversity and the precisely regulated tissue- and differentiation-specific expression patterns of keratins suggest that these proteins have specific functions in epithelia besides their well known maintenance of cell integrity. In the search for these specific functions, our previous results have demonstrated that the expression of K10, a keratin expressed in postmitotic suprabasal cells of the epidermis, prevents cell proliferation through the inhibition of Akt kinase activity. Given the roles of Akt in NF-kappa B signaling and the importance of these processes in the epidermis, a study was made into the possible alterations of the NF-kappa B pathway in transgenic mice expressing K10 in the proliferative basal layer. It was found that the inhibition of Akt, mediated by K10 expression, leads to impaired NF-kappa B activity. This appears to occur through the decreased expression of IKK beta and IKK gamma. Remarkably, increased production of tumor necrosis factor alpha and concomitant JNK activation was observed in the epidermis of these transgenic mice. These results confirm that keratin K10 functions in vivo include the control of many aspects of epithelial physiology, which affect the cells not only in a cell autonomous manner but also influence tissue homeostasis.
Santos
Mirentxu
M
Department of Cell and Molecular Biology, CIEMAT, Ave. Complutense 22, Madrid E-28040, Spain.
Perez
Paloma
P
Segrelles
Carmen
C
Ruiz
Sergio
S
Jorcano
José L
JL
Paramio
Jesús M
JM
D000818:Animals; D002478:Cells, Cultured; D004817:Epidermis / Q000502:physiology*; D017930:Genes, Reporter; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D053550:Keratin-10; D015603:Keratinocytes / Q000166:cytology / Q000502:physiology*; D007633:Keratins / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D016328:NF-kappa B / Q000235:genetics* / Q000502:physiology*; D010957:Plasmids; D012878:Skin Neoplasms / Q000235:genetics; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
C507493:KRT10 protein, human; C507491:Krt10 protein, mouse; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; D053550:Keratin-10; D007633:Keratins